Torres-Ferreira, J., Ramalho-Carvalho, J., Gómez, A., Menezes, F. D., Freitas, R., Oliveira, J., . . . Jerónimo, C. (2017). MiR-193b promoter methylation accurately detects prostate cancer in urine sediments and miR-34b/c or miR-129-2 promoter methylation define subsets of clinically aggressive tumors.
Citação norma ChicagoTorres-Ferreira, Jorge, et al. MiR-193b Promoter Methylation Accurately Detects Prostate Cancer in Urine Sediments and MiR-34b/c or MiR-129-2 Promoter Methylation Define Subsets of Clinically Aggressive Tumors. 2017.
Citação norma MLATorres-Ferreira, Jorge, et al. MiR-193b Promoter Methylation Accurately Detects Prostate Cancer in Urine Sediments and MiR-34b/c or MiR-129-2 Promoter Methylation Define Subsets of Clinically Aggressive Tumors. 2017.